WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2023)
Top biotech stocks in 2023 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$2.49B$437.86M$143.74M$181.47M$3.0743.35%N/A411.67%N/A2023-05-01
GMAB
GENMAB A
$24.64B$2.08B$1.10B$786.61M$1.2063.64%40.70%74.61%33.04%2023-05-10
UTHR
UNITED THERAPEUTICS CORP
$10.18B$1.94B$1.03B$727.30M$15.9814.88%2.33%50.75%10.96%2023-05-02
TECH
BIO-TECHNE CORP
$11.41B$1.12B$433.88M$261.82M$1.678.77%13.32%24.16%16.99%2023-05-02
NBIX
NEUROCRINE BIOSCIENCES INC
$9.37B$1.49B$236.60M$154.50M$1.6131.34%55.90%69.47%N/A2023-05-02
SIGA
SIGA TECHNOLOGIES INC
$414.43M$110.78M$44.65M$33.90M$0.46-17.13%55.28%-50.00%N/A2023-05-03
KNSA
KINIKSA PHARMACEUTICALS LTD
$795.88M$220.18M$16.47M$183.36M$2.64471.24%N/AN/AN/A2023-05-01
TBPH
THERAVANCE BIOPHARMA INC
$661.33M$51.35M$1.07B$872.13M$11.85-7.17%27.26%N/AN/A2023-05-03
INCY
INCYTE CORP
$15.66B$3.39B$599.64M$340.66M$1.5313.67%17.18%-64.42%N/A2023-05-01
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.26B$722.68M$307.70M$292.87M$2.3264.45%366.53%274.19%N/A2023-05-03
APVO
APTEVO THERAPEUTICS INC
$9.42M$6.78M$7.40M$6.40M$1.26-38.37%-14.25%N/A24.57%2023-03-29
BNTX
BIONTECH SE
$31.16B$18.20B$14.35B$10.12B$41.5514.43%N/A17.07%N/A2023-03-27
BMRN
BIOMARIN PHARMACEUTICAL INC
$16.93B$2.10B$267.52M$141.56M$0.7613.53%9.80%N/AN/A2023-04-25
HALO
HALOZYME THERAPEUTICS INC
$4.67B$660.12M$315.51M$202.13M$1.4848.91%15.83%-48.25%26.33%2023-05-08
VIR
VIR BIOTECHNOLOGY INC
$3.00B$1.62B$769.77M$515.84M$3.8947.51%259.04%-4.42%N/A2023-05-03
CORT
CORCEPT THERAPEUTICS INC
$2.35B$401.86M$115.47M$101.29M$0.959.80%20.34%-2.06%-3.58%2023-05-03
SELB
SELECTA BIOSCIENCES INC
$216.18M$110.78M$40.43M$35.38M$0.2430.21%251.31%N/AN/A2023-05-03
EXEL
EXELIXIS INC
$5.99B$1.61B$273.54M$182.28M$0.5712.27%28.91%-21.92%1.85%2023-05-02
CPRX
CATALYST PHARMACEUTICALS INC
$1.70B$214.20M$106.21M$83.08M$0.8052.10%N/A110.53%N/A2023-05-08
IMTX
IMMATICS NV
$516.76M$183.86M$52.13M$39.91M$0.60365.44%N/AN/AN/A2023-05-22
CMRX
CHIMERIX INC
$107.69M$33.82M$172.31M$172.17M$1.971,609.15%49.73%N/AN/A2023-05-15
XRTX
XORTX THERAPEUTICS INC
$6.24M$0.00$1.84M$1.84M$0.38N/AN/AN/AN/A2023-05-03
ICPT
INTERCEPT PHARMACEUTICALS INC
$560.88M$285.71M$245.46M$221.82M$6.569.57%16.89%N/AN/A2023-05-04
XENE
XENON PHARMACEUTICALS INC
$2.21B$9.43M-$123.63M-$124.94M-$2.06-48.83%97.87%N/AN/A2023-05-08
ACET
ADICET BIO INC
$253.00M$24.99M-$64.70M-$69.79M-$1.70156.83%N/AN/AN/A2023-05-10
LMNL
LIMINAL BIOSCIENCES INC
$120.54M$290.58k$1.75M$539.13k$0.12-41.73%-55.89%-96.49%N/A2023-05-08
PGEN
PRECIGEN INC
$242.11M$26.91M$45.67M$28.32M$0.1488.61%-34.28%N/AN/A2023-05-08
MRNA
MODERNA INC
$58.29B$19.26B$9.92B$8.36B$21.264.29%147.88%-29.86%N/A2023-05-02
PULM
PULMATRIX INC
$10.89M$4.82M-$17.12M-$21.85M-$6.95-28.21%60.53%N/AN/A2023-03-27
MOLN
MOLECULAR PARTNERS AG
$214.11M$203.87M$129.96M$126.72M$3.901,802.02%N/AN/AN/A2023-05-11
GRNA
GREENLIGHT BIOSCIENCES HOLDINGS PBC
$72.29M$4.17M-$149.47M-$149.93M$25.07187.33%N/A100.24%N/A
REGN
REGENERON PHARMACEUTICALS INC
$89.65B$12.17B$5.26B$4.34B$40.51-24.26%15.70%-46.98%29.16%2023-05-02
CDMO
AVID BIOSERVICES INC
$1.09B$140.69M$11.28M$116.47M$1.9021.31%16.85%1,087.50%N/A
ZYME
ZYMEWORKS INC
$525.14M$412.48M$147.24M$124.34M$1.911,446.03%51.45%N/AN/A2023-05-02
ZLAB
ZAI LAB LTD
$3.10B$215.04M-$426.71M-$443.29M-$4.6049.01%N/AN/AN/A2023-05-08
AADI
AADI BIOSCIENCE INC
$176.86M$10.99M-$61.86M-$62.59M$4.75-22.99%N/AN/AN/A2023-03-28
DBVT
DBV TECHNOLOGIES SA
$297.12M$4.84M-$83.04M-$96.27M-$0.62-15.14%-18.34%N/AN/A2023-05-01
LPCN
LIPOCINE INC
$26.29M$500.00k-$10.72M-$10.76M-$0.12-96.90%N/AN/AN/A2023-05-08
VACC
VACCITECH PLC
$93.16M$44.70M$6.43M$5.34M$0.1416,580.22%N/AN/AN/A
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$3.43B$883.00M$339.53M$220.21M$1.6710.48%N/A5.03%N/A2023-05-03
CRNX
CRINETICS PHARMACEUTICALS INC
$835.05M$4.74M-$162.53M-$163.92M-$3.15339.42%18.29%N/AN/A2023-03-28
ABCL
ABCELLERA BIOLOGICS INC
$2.11B$485.42M$276.25M$158.52M$0.5629.38%N/A0.00%N/A2023-05-08
LYRA
LYRA THERAPEUTICS INC
$62.06M$1.62M-$53.54M-$54.66M-$2.7911,492.86%N/AN/AN/A2023-03-27
SLGL
SOL-GEL TECHNOLOGIES LTD
$98.65M$3.88M-$14.36M-$14.92M-$0.65-87.58%86.09%N/AN/A2023-03-28
VRTX
VERTEX PHARMACEUTICALS INC
$80.83B$8.93B$4.44B$3.32B$12.9717.91%29.12%42.68%65.02%2023-05-03
SURF
SURFACE ONCOLOGY INC
$37.64M$30.00M-$56.75M-$63.59M-$1.141,016.49%18.52%N/AN/A2023-05-08
GNFT
GENFIT SA
$195.77M$85.58M$78.77M$67.26M-$19.281,322.63%N/AN/AN/A2023-04-13
FIXX
HOMOLOGY MEDICINES INC
$52.49M$3.21M-$1.69M-$5.01M-$0.09-90.56%N/AN/AN/A2023-05-15
ATRA
ATARA BIOTHERAPEUTICS INC
$275.31M$63.57M-$215.71M-$228.30M-$2.24212.55%N/AN/AN/A2023-05-03
VYNE
VYNE THERAPEUTICS INC
$8.45M$477.00k-$23.13M-$23.21M-$7.28-48.76%-36.39%N/AN/A2023-05-10
PRTA
PROTHENA CORP PUBLIC LTD CO
$2.47B$53.91M-$118.86M-$116.95M-$2.47-73.13%14.39%N/AN/A2023-05-09
CGEM
CULLINAN ONCOLOGY INC
$413.33M$0.00$153.43M$111.21M$2.46-100.00%N/AN/AN/A2023-05-15
VNDA
VANDA PHARMACEUTICALS INC
$383.30M$254.38M$14.03M$6.28M$0.11-5.32%9.03%-81.67%N/A2023-05-03
CBIO
CATALYST BIOSCIENCES INC
$6.55M$3.23M$12.22M$11.88M$0.38-53.33%33.21%N/AN/A2023-03-29
KDNY
CHINOOK THERAPEUTICS INC
$1.46B$6.13M-$172.15M-$187.87M-$2.92-88.13%-18.69%N/AN/A2023-05-10
HSTO
HISTOGEN INC
$5.00M$3.77M-$10.48M-$11.11M-$3.46265.21%-36.10%N/AN/A2023-05-10
OMER
OMEROS CORP
$242.52M$0.00$71.07M$47.42M$0.76N/A-100.00%-75.64%N/A2023-05-08
TCRT
ALAUNOS THERAPEUTICS INC
$113.34M$2.92M-$31.82M-$37.73M-$0.17634.17%-14.48%N/AN/A2023-05-15
SAGE
SAGE THERAPEUTICS INC
$2.56B$7.69M-$531.66M-$532.78M-$8.9821.85%N/AN/AN/A2023-05-01
RNA
AVIDITY BIOSCIENCES INC
$1.42B$9.22M-$172.61M-$174.00M-$3.34-1.09%N/AN/AN/A2023-05-08
CRDF
CARDIFF ONCOLOGY INC
$67.91M$386.00k-$38.47M-$38.73M-$0.897.52%-5.25%N/AN/A2023-05-03
SRRK
SCHOLAR ROCK HOLDING CORP
$406.00M$33.19M-$124.62M-$134.50M-$2.2676.41%N/AN/AN/A2023-05-15
IMAB
I-MAB
$247.89M$16.98M-$312.67M-$320.16M-$4.00-92.41%N/AN/AN/A2023-03-30
BLU
BELLUS HEALTH INC
$954.32M$11.59k-$52.53M-$55.13M-$0.48-6.58%-38.21%N/AN/A2023-03-27
AFMD
AFFIMED NV
$98.71M$43.99M-$90.66M-$91.49M-$0.64-4.09%78.72%N/AN/A
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
$87.72M$551.00k-$15.50M-$16.30M-$1.54-96.53%46.67%N/AN/A2023-03-29
LUMO
LUMOS PHARMA INC
$27.29M$1.52M-$31.03M-$31.06M-$3.71562.17%-44.42%N/AN/A2023-05-08
RPTX
REPARE THERAPEUTICS INC
$408.16M$131.83M-$9.72M-$29.05M-$0.691,634.61%N/AN/AN/A2023-05-03
AUTL
AUTOLUS THERAPEUTICS PLC
$315.00M$6.36M-$156.88M-$148.84M-$1.57172.96%N/AN/AN/A2023-05-04
ORTX
ORCHARD THERAPEUTICS PLC
$62.20M$22.66M-$147.21M-$150.66M-$11.801,252.54%N/AN/AN/A2023-05-11
AUPH
AURINIA PHARMACEUTICALS INC
$1.47B$134.03M-$103.65M-$108.18M-$0.76193.89%217.11%N/AN/A2023-05-08
PRQR
PROQR THERAPEUTICS NV
$256.04M$3.97M-$67.26M-$72.67M-$1.0250.79%25.11%N/AN/A2023-03-29
PRTC
PURETECH HEALTH PLC
$777.05M$17.39M-$49.52M-$60.56M-$2.1047.76%N/AN/AN/A2023-04-26
ITOS
ITEOS THERAPEUTICS INC
$486.87M$267.63M$149.54M$96.65M$2.72-22.38%N/A-55.41%N/A2023-05-10
RXRX
RECURSION PHARMACEUTICALS INC
$1.28B$39.84M-$227.72M-$239.48M-$1.36291.46%N/AN/AN/A2023-05-08
LIFE
ATYR PHARMA INC
$102.07M$10.39M-$43.64M-$45.34M-$1.60N/AN/AN/AN/A2023-05-08
SEER
SEER INC
$239.68M$15.49M-$87.07M-$92.97M-$1.49134.14%N/AN/AN/A2023-05-02
INMB
INMUNE BIO INC
$117.73M$374.00k-$27.30M-$27.30M-$1.52106.63%N/AN/AN/A2023-05-03
VCNX
VACCINEX INC
$17.51M$50.00k-$19.18M-$19.37M-$0.51-94.44%N/AN/AN/A2023-03-29
CARA
CARA THERAPEUTICS INC
$265.40M$41.87M-$83.80M-$85.47M-$1.5981.81%115.02%N/AN/A2023-05-08
MEIP
MEI PHARMA INC
$31.98M$62.57M-$29.63M-$31.16M-$0.2378.01%62.08%N/AN/A2023-05-22
ONTX
ONCONOVA THERAPEUTICS INC
$15.28M$226.00k-$17.29M-$17.31M-$0.81-0.44%-22.66%N/AN/A2023-05-09
MRNS
MARINUS PHARMACEUTICALS INC
$307.92M$25.48M-$5.09M-$19.82M-$0.5166.03%N/AN/AN/A2023-05-10
PLUR
PLURI INC
$35.51M$323.00k-$32.20M-$33.11M-$1.02N/A45.23%N/AN/A2023-05-11
STOK
STOKE THERAPEUTICS INC
$337.73M$12.41M-$100.65M-$101.07M-$2.60N/AN/AN/AN/A2023-05-08
VCYT
VERACYTE INC
$1.59B$296.54M-$7.18M-$36.56M-$0.5135.09%32.74%N/AN/A2023-05-01
RXDX
PROMETHEUS BIOSCIENCES INC
$5.10B$6.81M-$140.26M-$141.75M-$3.49117.61%N/AN/AN/A2023-05-11
NRIX
NURIX THERAPEUTICS INC
$417.89M$38.63M-$169.55M-$180.36M-$3.7129.84%N/AN/AN/A2023-04-05
CASI
CASI PHARMACEUTICALS INC
$22.31M$37.01M-$23.98M-$27.08M-$1.9443.26%N/AN/AN/A2023-03-27
XBIT
XBIOTECH INC
$101.36M$4.01M-$30.97M-$32.90M-$1.08-78.20%N/AN/AN/A2023-05-08
UBX
UNITY BIOTECHNOLOGY INC
$59.51M$236.00k-$54.19M-$59.93M-$6.31-95.07%N/AN/AN/A2023-05-08
DTIL
PRECISION BIOSCIENCES INC
$77.91M$25.10M-$101.52M-$111.64M-$1.27-78.28%31.09%N/AN/A2023-05-08
AGIO
AGIOS PHARMACEUTICALS INC
$1.20B$14.24M-$213.24M-$231.80M-$4.23N/A-19.83%N/AN/A2023-05-03
SYBX
SYNLOGIC INC
$40.55M$1.67M-$59.11M-$64.54M-$0.8743.37%-7.38%N/AN/A2023-03-27
NTLA
INTELLIA THERAPEUTICS INC
$3.37B$52.12M-$466.61M-$474.19M-$6.1657.69%14.82%N/AN/A2023-05-03
VRDN
VIRIDIAN THERAPEUTICS INC
$1.10B$1.77M-$129.10M-$129.87M-$4.05-40.20%-15.04%N/AN/A2023-05-10
RAPT
RAPT THERAPEUTICS INC
$598.31M$1.53M-$81.03M-$83.84M-$2.58-59.95%N/AN/AN/A2023-05-09
CERT
CERTARA INC
$3.77B$335.64M$89.00M$14.73M$0.0917.32%N/AN/AN/A2023-05-03
BCYC
BICYCLE THERAPEUTICS PLC
$616.93M$14.46M-$107.21M-$112.72M-$3.8023.65%47.67%N/AN/A2023-05-03
IDYA
IDEAYA BIOSCIENCES INC
$671.61M$50.93M-$56.55M-$58.66M-$1.4282.28%N/AN/AN/A2023-05-08

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Mar 2023?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the top biotech stock with a Zen Score of 66, which is 38 points higher than the biotech industry average of 28. It passed 22 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -16.94% over the past year, overperforming other biotech stocks by 10 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $61.63, an upside of 47.82% from Harmony Biosciences Holdings's current stock price of $41.69.

Harmony Biosciences Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Harmony Biosciences Holdings, 50% have issued a Strong Buy rating, 37.5% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Genmab A (NASDAQ:GMAB)


Genmab A (NASDAQ:GMAB) is the second best biotech stock with a Zen Score of 65, which is 37 points higher than the biotech industry average of 28. It passed 22 out of 33 due diligence checks and has strong fundamentals. Genmab A has seen its stock return 6.29% over the past year, overperforming other biotech stocks by 33 percentage points.

Genmab A has an average 1 year price target of $36.95, a downside of -1.11% from Genmab A's current stock price of $37.36.

Genmab A stock has a consensus Hold recommendation according to Wall Street analysts. Of the 6 analysts covering Genmab A, 0% have issued a Strong Buy rating, 16.67% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. United Therapeutics (NASDAQ:UTHR)


United Therapeutics (NASDAQ:UTHR) is the third best biotech stock with a Zen Score of 63, which is 35 points higher than the biotech industry average of 28. It passed 20 out of 33 due diligence checks and has strong fundamentals. United Therapeutics has seen its stock return 22.96% over the past year, overperforming other biotech stocks by 50 percentage points.

United Therapeutics has an average 1 year price target of $285.91, an upside of 29.99% from United Therapeutics's current stock price of $219.94.

United Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering United Therapeutics, 54.55% have issued a Strong Buy rating, 36.36% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 9.09% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Kineta (NASDAQ:KA)


Kineta (NASDAQ:KA) has an annual dividend yield of 316.77%, which is 274 percentage points higher than the biotech industry average of 42.73%.

Kineta's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Carisma Therapeutics (NASDAQ:CARM)


Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of 11.26%, which is -31 percentage points lower than the biotech industry average of 42.73%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.84%, which is -35 percentage points lower than the biotech industry average of 42.73%.

Siga Technologies's dividend payout ratio of 97.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.61% in the last day, and down -0.47% over the last week. Pharming Group Nv was the among the top gainers in the biotechnology industry, gaining 32.74% yesterday.

Pharming shares are trading higher after the company announced FDA approval of Joenja as the first and only treatment indicated for APDS. It is expected to launch in the US in early April.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Greenlight Biosciences Holdings (NASDAQ:GRNA)


Greenlight Biosciences Holdings (NASDAQ:GRNA) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Greenlight Biosciences Holdings has a valuation score of 100, which is 69 points higher than the biotech industry average of 31. It passed 7 out of 7 valuation due diligence checks.

Greenlight Biosciences Holdings's stock has dropped -95.44% in the past year. It has underperformed other stocks in the biotech industry by -68 percentage points.

2. Aptevo Therapeutics (NASDAQ:APVO)


Aptevo Therapeutics (NASDAQ:APVO) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Aptevo Therapeutics has a valuation score of 100, which is 69 points higher than the biotech industry average of 31. It passed 7 out of 7 valuation due diligence checks.

Aptevo Therapeutics's stock has dropped -73.42% in the past year. It has underperformed other stocks in the biotech industry by -46 percentage points.

3. Vascular Biogenics (NASDAQ:VBLT)


Vascular Biogenics (NASDAQ:VBLT) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Vascular Biogenics has a valuation score of 100, which is 69 points higher than the biotech industry average of 31. It passed 7 out of 7 valuation due diligence checks.

Vascular Biogenics's stock has dropped -90.82% in the past year. It has underperformed other stocks in the biotech industry by -64 percentage points.

Are biotech stocks a good buy now?

50.36% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 92.66% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 17.88x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.